Response to: Tocilizumab, neuromyelitis optica (NMO), and multiple sclerosis.
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
Works by Beauchemin, Philippe
Results: 9
1
2
MS arising during Tocilizumab therapy for rheumatoid arthritis.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 2, p. 254, doi. 10.1177/1352458515623862
- By:
- Publication type:
- Article
3
Case Report: Acute Necrotizing Encephalopathy Following COVID-19 Vaccine.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.872734
- By:
- Publication type:
- Article
4
Hypogammaglobulinemia and Infection Risk in an Ocrelizumab-treated Multiple Sclerosis Cohort.
- Published in:
- Canadian Journal of Neurological Sciences, 2024, v. 51, n. 6, p. 811, doi. 10.1017/cjn.2024.21
- By:
- Publication type:
- Article
5
Virtual Management of Multiple Sclerosis: Providing Access or Just Phoning it in?
- Published in:
- Canadian Journal of Neurological Sciences, 2024, v. 51, n. 1, p. 113, doi. 10.1017/cjn.2023.41
- By:
- Publication type:
- Article
6
Videoconferencing and Multiple Sclerosis Management: Stopgap or Stay Tuned?
- Published in:
- Canadian Journal of Neurological Sciences, 2022, v. 49, n. 3, p. 402, doi. 10.1017/cjn.2021.113
- By:
- Publication type:
- Article
7
Acephalgic Intracranial Hypotension: Subdural Haematoma Resolution After Blood Patch.
- Published in:
- 2022
- By:
- Publication type:
- Letter
8
Neurocognitive Changes in Tertiary Neurosyphilis: A Retrospective Chart Review.
- Published in:
- Canadian Journal of Neurological Sciences, 2014, v. 41, n. 4, p. 452, doi. 10.1017/S0317167100018485
- By:
- Publication type:
- Article
9
Slow Alpha Variant: A Report of a 3 for 1 Ratio Subharmonic.
- Published in:
- 2012
- By:
- Publication type:
- Case Study